彭博分析師料恆大(03333.HK)可透過出售壽險業務 籌6億美元
中國恆大(03333.HK)陷債務危機,彭博行業研究分析師Steven Lam認爲,集團還可透過出售其壽險業務以獲取資金。按0.5倍的帳面價值計算,恆大所持恆大人壽50%的股份,或可以6億美元轉手。
事實上,自恆大2015年收購恆大人壽以來,後者的市佔率已增長超過8倍,而過去4年每年都實現盈利。不過,其快速增長的代價是較低的償付能力充足率,截至6月底爲110%,而6家大型壽險公司的平均比率爲239%,意味着無論是誰接手恆大的股份,可能都需要再投入22億美元,將有關比率提升至200%以上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.